Mapping the human toxome by systems toxicology.
暂无分享,去创建一个
Liang Zhao | Alexandra Maertens | Thomas Hartung | Andre Kleensang | Mounir Bouhifd | Helena T Hogberg | Alexandra Maertens | T. Hartung | H. Hogberg | Liang Zhao | A. Kleensang | M. Bouhifd | A. Maertens
[1] Thomas Hartung,et al. Food for Thought ... on mapping the human toxome. , 2011, ALTEX.
[2] Melvin E Andersen,et al. Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program. , 2014, ALTEX.
[3] Thomas Hartung,et al. Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[4] T. Hartung. Evidence-based toxicology - the toolbox of validation for the 21st century? , 2010, ALTEX.
[5] S. Imazato,et al. In vitro Estrogenicity of Resin Composites , 2004, Journal of dental research.
[6] C. Sonnenschein,et al. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. , 1991, Environmental health perspectives.
[7] T. Knudsen,et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.
[8] G. Daston,et al. Toxicogenomic Approach to Endocrine Disrupters: Identification of a Transcript Profile Characteristic of Chemicals with Estrogenic Activity , 2004, Toxicologic pathology.
[9] R. Kiyama,et al. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. , 2011, Environmental pollution.
[10] C. K. Kwoh,et al. Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.
[11] H. Fischer. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. , 2005, Biotechnology annual review.
[12] L. Smirnova,et al. Metabolomics in toxicology and preclinical research. , 2013, ALTEX.
[13] Eric E. Schadt,et al. Moving toward a system genetics view of disease , 2007, Mammalian Genome.
[14] J. Gustafsson,et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.
[15] Thomas Hartung,et al. A Toxicology for the 21st Century—Mapping the Road Ahead , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[16] Anne Marie Vinggaard,et al. Endocrine-Disrupting Potential of Bisphenol A, Bisphenol A Dimethacrylate, 4-n-Nonylphenol, and 4-n-Octylphenol in Vitro: New Data and a Brief Review , 2007, Environmental health perspectives.
[17] Uri Alon,et al. An Introduction to Systems Biology , 2006 .
[18] D. Lauffenburger,et al. Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.
[19] Thomas Hartung,et al. Food for thought... on evidence-based toxicology. , 2009, ALTEX.
[20] Mardas Daneshian,et al. Validation and quality control of replacement alternatives - Current status and future challenges , 2012 .
[21] Thomas Hartung,et al. Review: Toxicometabolomics , 2013, Journal of applied toxicology : JAT.
[22] Atul J. Butte,et al. Unsupervised knowledge discovery in medical databases using relevance networks , 1999, AMIA.
[23] T. Hartung. Toxicology for the twenty-first century , 2009, Nature.
[24] Thomas Hartung,et al. Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.
[25] Thomas Hartung,et al. Food for thought...on alternative methods for chemical safety testing. , 2010, ALTEX.
[26] P. Y. Ng,et al. Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.
[27] Thomas Hartung,et al. Food for thought ... on alternative methods for nanoparticle safety testing. , 2010, ALTEX.
[28] J. Gustafsson,et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.
[29] David M. Reif,et al. Endocrine Profiling and Prioritization of Environmental Chemicals Using ToxCast Data , 2010, Environmental health perspectives.
[30] P. D’haeseleer,et al. Mining the gene expression matrix: inferring gene relationships from large scale gene expression data , 1998 .
[31] V. Yong,et al. Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. , 2013, Molecular immunology.
[32] J. McLachlan,et al. Estrogens and development. , 1987, Environmental health perspectives.
[33] Thomas Hartung,et al. From alternative methods to a new toxicology. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] J. Sumpter,et al. Environmentally persistent alkylphenolic compounds are estrogenic. , 1994, Endocrinology.
[35] Alexandra Maertens,et al. Integrated testing strategies for safety assessments. , 2013, ALTEX.
[36] Bor-Sen Chen,et al. Quantitative inference of dynamic regulatory pathways via microarray data , 2004, BMC Bioinformatics.
[37] Y. Shimohigashi,et al. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. , 2006, Toxicology letters.
[38] Y. Shimohigashi,et al. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor γ (ERRγ) with high constitutive activity , 2006 .
[39] Uri Alon,et al. Simplicity in biology , 2007, Nature.
[40] Thomas Hartung,et al. Pathways of Toxicity. , 2014, ALTEX.
[41] T. Hartung,et al. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. , 2008, Neurotoxicology.
[42] S Fuhrman,et al. Reveal, a general reverse engineering algorithm for inference of genetic network architectures. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[43] U. Alon. Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.
[44] Donald G Robertson,et al. Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[45] Bas J Blaauboer,et al. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. , 2012, ALTEX.
[46] M. Peitsch,et al. The application of systems biology to drug discovery. , 2006, Current opinion in chemical biology.
[47] Hsien-Ming Wu,et al. Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα) , 2013, PloS one.
[48] Zhiping Weng,et al. Computational inference of transcriptional regulatory networks from expression profiling and transcription factor binding site identification. , 2004, Nucleic acids research.
[49] Thomas Hartung,et al. Food for Thought … Systems Toxicology , 2012 .
[50] Thomas Hartung,et al. Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice , 2013, Archives of Toxicology.
[51] Thomas Hartung,et al. Food for thought... on the economics of animal testing. , 2009, ALTEX.
[52] L Earl Gray,et al. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[53] Bor-Sen Chen,et al. Integrated cellular network of transcription regulations and protein-protein interactions , 2010, BMC Systems Biology.